Amgen Inc. is a multinational biopharmaceutical company focused on discovering, developing, and delivering innovative human therapeutics derived from biotechnology. Its portfolio features blockbuster products such as Prolia and XGEVA (denosumab) for osteoporosis and bone diseases, generating $6.